Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations

PHASE3

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped The manufacturer Arog Pharmaceuticals Inc has terminated the Agreement Concerning the Support of an Investigator Initiated Trial this became valid on 2020/03/09

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: chemotherapy (Mitoxantrone, Cytarabine)
DRUG: Placebo
DRUG: Crenolanib
OTHER: Allogeneic stem cell transplantation

Sponsor

University of Ulm